Literature DB >> 33948694

Reasons to go for thulium-based anatomical endoscopic enucleation of the prostate.

B Becker1, C Netsch2, G Bozzini3, T R W Herrmann4, T Bach5, D Enikeev6, A J Gross2.   

Abstract

PURPOSE: To summarize the current evidence and the reasons to go for thulium-based anatomical endoscopic enucleation of the prostate (AEEP).
METHODS: This review discusses the available literature on thulium-based AEEP.
RESULTS: Thulium lasers operate at a wavelength between 1940 and 2013 nm. This wavelength, which has a low penetration depth in water, allows to perform smooth cuts in the prostatic tissue and allows urologists to perform various procedures: resection, vaporization, enucleation, or vapoenucleation of the prostate. Depending on the type of thulium laser, it can be used either in a continuous, or pulsed mode.
CONCLUSION: In recent years, an increasing amount of evidence has described the thulium laser as a minimally invasive and size-independent treatment option for benign prostatic enlargement with excellent long-term results.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  BPO; Enucleation; Laser surgery; ThuLEP; ThuVEP; Thulium laser

Year:  2021        PMID: 33948694     DOI: 10.1007/s00345-021-03704-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  48 in total

1.  Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial.

Authors:  B Becker; T R W Herrmann; A J Gross; C Netsch
Journal:  World J Urol       Date:  2018-05-05       Impact factor: 4.226

2.  Thulium:YAG vapoenucleation in large volume prostates.

Authors:  Thorsten Bach; Christopher Netsch; Laura Pohlmann; Thomas R W Herrmann; Andreas J Gross
Journal:  J Urol       Date:  2011-10-20       Impact factor: 7.450

3.  Safety and effectiveness of Thulium VapoEnucleation of the prostate (ThuVEP) in patients on anticoagulant therapy.

Authors:  Christopher Netsch; M Stoehrer; M Brüning; A Gabuev; T Bach; T R W Herrmann; A J Gross
Journal:  World J Urol       Date:  2013-05-09       Impact factor: 4.226

Review 4.  Thulium: YAG 2 mum cw laser prostatectomy: where do we stand?

Authors:  T Bach; S J Xia; Y Yang; S Mattioli; G M Watson; A J Gross; T R W Herrmann
Journal:  World J Urol       Date:  2010-03-05       Impact factor: 4.226

5.  Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach.

Authors:  C Netsch; T Bach; T R W Herrmann; O Neubauer; A J Gross
Journal:  World J Urol       Date:  2012-06-24       Impact factor: 4.226

6.  Enucleation is enucleation is enucleation is enucleation.

Authors:  Thomas R W Herrmann
Journal:  World J Urol       Date:  2016-09-01       Impact factor: 4.226

7.  [Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia].

Authors:  Shu-jie Xia; Yi-nan Zhang; Jun Lu; Xiao-wen Sun; Jie Zhang; Yi-yong Zhu; Wei-guo Li
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-11-30

8.  Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up.

Authors:  César Vargas; Alejandro García-Larrosa; Santiago Capdevila; Ainhoa Laborda
Journal:  J Endourol       Date:  2014-03-31       Impact factor: 2.942

9.  Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.

Authors:  T Bach; G Wendt-Nordahl; M S Michel; T R W Herrmann; A J Gross
Journal:  World J Urol       Date:  2009-01-28       Impact factor: 4.226

10.  Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction.

Authors:  Thomas R W Herrmann; T Bach; F Imkamp; A Georgiou; M Burchardt; M Oelke; A J Gross
Journal:  World J Urol       Date:  2010-02       Impact factor: 4.226

View more
  2 in total

1.  [Minimally invasive treatment options for the management of benign prostatic hyperplasia].

Authors:  J Franz; R Suarez-Ibarrola; D S Schoeb; C Gratzke; A Miernik
Journal:  Urologe A       Date:  2021-11-05       Impact factor: 0.639

2.  TURPxit or not: contemporary management options for benign prostatic obstruction.

Authors:  Thomas R W Herrmann; Vincent Misrai; Fernando Gómez Sancha; Thorsten Bach
Journal:  World J Urol       Date:  2021-07       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.